LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.89 | 771.67 | 1165 | 5541 | 0.2102 | 0.1558 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.11 | 771.67 | 1003 | 5941 | 0.1688 | 0.0931 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.11 | 771.67 | 1159 | 5941 | 0.1951 | 0.1481 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.33 | 771.67 | 1009 | 6392 | 0.1578 | 0.0919 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.33 | 771.67 | 1105 | 6392 | 0.1729 | 0.1249 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.55 | 771.67 | 954 | 6829 | 0.1397 | 0.0698 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.55 | 771.67 | 1081 | 6829 | 0.1583 | 0.1131 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.77 | 771.67 | 1018 | 7256 | 0.1403 | 0.0895 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.77 | 771.67 | 1066 | 7256 | 0.1469 | 0.1051 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.99 | 771.67 | 995 | 7690 | 0.1294 | 0.0796 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.99 | 771.67 | 1025 | 7690 | 0.1333 | 0.0894 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.21 | 771.67 | 964 | 8085 | 0.1192 | 0.0679 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.21 | 771.67 | 928 | 8085 | 0.1148 | 0.0559 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 60.44 | 771.67 | 1001 | 8530 | 0.1173 | 0.0779 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 60.44 | 771.67 | 918 | 8530 | 0.1076 | 0.0514 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 62.66 | 771.67 | 1021 | 8978 | 0.1137 | 0.0823 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 62.66 | 771.67 | 873 | 8978 | 0.0972 | 0.0355 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 64.88 | 771.67 | 974 | 9447 | 0.1031 | 0.0666 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 64.88 | 771.67 | 790 | 9447 | 0.0836 | 0.0065 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 67.10 | 771.67 | 1018 | 9800 | 0.1039 | 0.0785 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 67.10 | 771.67 | 733 | 9800 | 0.0748 | -0.0139 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.32 | 771.67 | 1056 | 10212 | 0.1034 | 0.0878 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 69.32 | 771.67 | 683 | 10212 | 0.0669 | -0.0322 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.54 | 771.67 | 1012 | 10532 | 0.0961 | 0.0746 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 71.54 | 771.67 | 635 | 10532 | 0.0603 | -0.0504 | MN20160304_L01 | L09 |